ARTICLE | Management Tracks
New CMOs at Arcus, Enanta
Plus Lamba becomes CFO at ImmPACT, and updates from Appia Bio and Quanterix
August 10, 2022 12:30 AM UTC
Oncology company Arcus Biosciences Inc. (NYSE:RCUS) hired Dimitry Nuyten as CMO to oversee a clinical development organization that includes nearly 200 employees and six clinical-stage programs targeting TIGIT, the adenosine axis, HIF-2a and PD-1. Nuyten was CMO of Nektar Therapeutics (NASDAQ:NKTR) and Aduro Biotech Inc.
Scott Rottinghaus became SVP and CMO at Enanta Pharmaceuticals Inc. (NASDAQ:ENTA), a viral infections and liver disease company. Rottinghaus was VP and head of clinical development for hematology and nephrology at Alexion Pharmaceuticals Inc., which was acquired by AstraZeneca plc (LSE:AZN; NASDAQ:AZN)...